insights_auto
Why is DAP down 2,87%?
Dive Deeperchevron_right
DAP:ETR
Danaher Corp
202,80 €
arrow_downward
-2,87%(-6,00) 1D
23-окт., 16:35:52 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DAP...
Open
206,00 €
High
206,30 €
Low
202,10 €
Mkt. cap
162,16 млд
Avg. vol.
562,00
Volume
111,00
52-wk high
208,30 €
52-wk low
138,20 €
No. of employees
59 миң
Open
206,00 €
High
206,30 €
Low
202,10 €
Mkt. cap
162,16 млд
Avg. vol.
562,00
Volume
111,00
52-wk high
208,30 €
52-wk low
138,20 €
No. of employees
59 миң
News stories
From web sources and news partners
Yahoo Finance
·
3 күн мурун
What Does Danaher (DHR) FDA Clearance For AI AFib Detection Mean Now?
Investing.com
·
3 күн мурун
UBS reiterates Danaher stock Buy rating on Q3 results and outlook
Investing.com
·
3 күн мурун
Stifel raises Danaher stock price target to $260 on growth outlook
Yahoo Finance
·
3 күн мурун
Danaher (DHR) Q3 Earnings Fuel Stock Gains On Margin Expansion
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corp